Zacks Investment Research on MSN
Novartis' Phase III Malaria Study Meets Key Non-Inferiority Endpoint
Novartis NVS reported positive top-line data from a late-stage study of its investigational new malaria treatment candidate, ...
Developed by British drugmaker GSK, RTS,S/AS01E in 2021 became the first malaria vaccine to be recommended by the World ...
Metabolism is known for its intricate adjustments to meet the needs of an organism. Due to demands of adaptation, parasite metabolic pathways are greatly altered from those of their hosts. A key ...
The study of GanLum (KLU156) – a combination of novel drug ganaplacide with established antimalarial lumefantrine – showed ...
Thought LeadersProfessor Karine Le RochDirector of the Center for Infectious Disease and Vector ResearchUniversity of California, Riverside As part of World Malaria Day 2022, we interview Karine Le ...
The development and implementation of a malaria vaccine would constitute a major breakthrough for global health. Recently, numerous new candidates have entered clinical testing, following strategies ...
Twenty malaria-naive volunteers received a recombinant Plasmodium falciparum malaria vaccine (RTS,S) containing 19 NANP repeats and the carboxy terminus (amino acids 210-398) of the circumsporozoite ...
A major tool against malaria in Africa has been the use of rapid diagnostic tests, which have been part of the 'test-treat-track' strategy in Ethiopia, the second most-populated country in Africa. But ...
Scientists from Sanaria Inc., and collaborators at multiple institutions publish results in Nature reporting "In vitro production of infectious Plasmodium falciparum sporozoites." Sanaria ® Plasmodium ...
[NEW YORK, SciDev.Net] An international study published in the Malaria Journal claims that a widely used test for detecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results